Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial (149404)

ARTG ID 149404

ARTG Name

ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial

Product name

ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial

ARTG Date

21 May 2009

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

Tocilizumab

Licence category

REPI

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial, Roche Products Pty Ltd, CON-867

16 September 2021

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from 16 September 2021 until supply of the affected clinical trial labelled batches 1163406, 1164929, 1163292, 1163279, 1162729, 1163299, 1164608, and 1164287 is exhausted.